Literature DB >> 7081220

Detection of heterozygotes in maple-syrup-urine disease: measurements of branched-chain alpha-ketoacid dehydrogenase and its components in cell cultures.

D T Chuang, L S Ku, D S Kerr, R P Cox.   

Abstract

To detect heterozygotes for maple-syrup-urine disease (MSUD), activities of branched-chain-alpha-ketoacid (BCKA) dehydrogenase and its components in skin fibroblasts of two obligatory heterozygotes and amnion cells of a fetus at risk were measured. Intact heterozygous cells were found to decarboxylate [1-14C] alpha-ketoisovalerate at rates equal to or only slightly lower than normal subjects. The inability to differentiate heterozygotes from normals with the intact cell assay confirms earlier studies with intact leukocytes using [1-14C]leucine as substrate. By contrast, measurements of BCKA dehydrogenase activity with disrupted cell suspensions showed MSUD heterozygotes with 30%--60% of normal activity. Moreover, biphasic kinetics in heterozygous cells were observed with increasing substrate concentrations. The altered biphasic kinetics probably reflect expression of the normal allele in the early hyperbolic portion of the curve of the mutant allele in the later secondary rise at high substrate concentrations. Assays of component activities showed concordant E1 decarboxylase deficiency in both heterozygous- and homozygous-affected cells, whereas the E3, dihydrolipoyl dehydrogenase-component, activity was normal. The above results taken together appear to provide an approach to detection of the heterozygote in MSUD.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081220      PMCID: PMC1685326     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  Subcellular distribution and cofactor function of human branched chain alpha-ketoacid dehydrogenase in normal and mutant cultured skin fibroblasts.

Authors:  D J Danner; L J Elsas
Journal:  Biochem Med       Date:  1975-05

2.  THE DIAGNOSIS OF MAPLE SYRUP URINE DISEASE (BRANCHED- CHAIN KETOACIDURIA) BY THE IN VITRO STUDY OF THE PERIPHERAL LEUKOCYTE.

Authors:  J DANCIS; J HUTZLER; M LEVITZ
Journal:  Pediatrics       Date:  1963-08       Impact factor: 7.124

3.  Studies on the physiological functions of thiamine. I. The effects of thiamine deficiency and thiamine antagonists on the oxidation of alpha-keto acids by rat tissues.

Authors:  C J GUBLER
Journal:  J Biol Chem       Date:  1961-12       Impact factor: 5.157

4.  Maple syrup urine disease: coenzyme function and prenatal monitoring.

Authors:  L J Elsas; J H Priest; F B Wheeler; D J Danner; B A Pask
Journal:  Metabolism       Date:  1974-06       Impact factor: 8.694

5.  Enzyme activity in classical and variant forms of maple syrup urine disease.

Authors:  J Dancis; J Hutzler; S E Snyderman; R P Cox
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

6.  Evaluation of a heterozygote test for maple syrup urine disease in leucocytes and cultured fibroblasts.

Authors:  U Langenbeck; H W Rüdiger; M Schulze-Schencking; W Keller; D Brackertz; H W Goedde
Journal:  Humangenetik       Date:  1971

7.  Maple syrup urine disease: branched-chain keto acid decarboxylation in fibroblasts as measured with amino acids and keto acids.

Authors:  J Dancis; J Hutzler; R P Cox
Journal:  Am J Hum Genet       Date:  1977-05       Impact factor: 11.025

8.  Purification and characterization of branched chain alpha-ketoacid dehydrogenase from bovine liver mitochondria.

Authors:  D J Danner; S K Lemmon; J C Besharse; L J Elsas
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

9.  Activities of branched-chain 2-oxo acid dehydrogenase and its components in skin fibroblasts from normal and classical-maple-syrup-urine-disease subjects.

Authors:  D T Chuang; W L Niu; R P Cox
Journal:  Biochem J       Date:  1981-10-15       Impact factor: 3.857

10.  Clonal growth in vitro of epithelial cells from normal human tissues.

Authors:  S J CIECIURA; P I MARCUS; T T PUCK
Journal:  J Exp Med       Date:  1956-10-01       Impact factor: 14.307

View more
  6 in total

1.  A simple and rapid enzymatic assay for the branched-chain alpha-ketoacid dehydrogenase complex using high-performance liquid chromatography.

Authors:  G Tajima; H Yofune; A D Bahagia Febriani; Y Nishimura; H Ono; N Sakura
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  Successful domino liver transplantation in maple syrup urine disease using a related living donor.

Authors:  F H Feier; I K Miura; E A Fonseca; G Porta; R Pugliese; A Porta; I V D Schwartz; A V B Margutti; J S Camelo; S N Yamaguchi; A T Taveira; H Candido; M Benavides; V Danesi; T Guimaraes; M Kondo; P Chapchap; J Seda Neto
Journal:  Braz J Med Biol Res       Date:  2014-04-25       Impact factor: 2.590

3.  Evidence for both a regulatory mutation and a structural mutation in a family with maple syrup urine disease.

Authors:  B Zhang; H J Edenberg; D W Crabb; R A Harris
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

4.  Molecular basis of maple syrup urine disease: novel mutations at the E1 alpha locus that impair E1(alpha 2 beta 2) assembly or decrease steady-state E1 alpha mRNA levels of branched-chain alpha-keto acid dehydrogenase complex.

Authors:  J L Chuang; C R Fisher; R P Cox; D T Chuang
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

5.  Altered phosphorylation state of branched-chain 2-oxo acid dehydrogenase in a branched-chain acyltransferase deficient human fibroblast cell line.

Authors:  R S Eisenstein; G Hoganson; R H Miller; A E Harper
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

6.  Maple syrup urine disease: two different forms within a single family.

Authors:  J Frézal; O Amédée-Manesme; G Mitchell; S Heuertz; F Rey; J Rey; J M Saudubray
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.